AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹58 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| Equity - Authorised | ₹454 Cr | ₹179 Cr | ₹179 Cr | ₹179 Cr | ₹66 Cr |
| Equity - Issued | ₹58 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| Equity Paid Up | ₹58 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹32,595 Cr | ₹29,784 Cr | ₹26,781 Cr | ₹24,517 Cr | ₹21,871 Cr |
| Securities Premium | ₹75 Cr | ₹418 Cr | ₹418 Cr | ₹418 Cr | ₹418 Cr |
| Capital Reserves | ₹122 Cr | ₹122 Cr | ₹122 Cr | ₹82 Cr | ₹82 Cr |
| Profit & Loss Account Balance | ₹30,222 Cr | ₹26,801 Cr | ₹23,910 Cr | ₹22,519 Cr | ₹20,137 Cr |
| General Reserves | ₹226 Cr | ₹813 Cr | ₹813 Cr | ₹813 Cr | ₹813 Cr |
| Other Reserves | ₹1,951 Cr | ₹1,630 Cr | ₹1,518 Cr | ₹685 Cr | ₹422 Cr |
| Reserve excluding Revaluation Reserve | ₹32,595 Cr | ₹29,784 Cr | ₹26,781 Cr | ₹24,517 Cr | ₹21,871 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹32,653 Cr | ₹29,843 Cr | ₹26,840 Cr | ₹24,576 Cr | ₹21,930 Cr |
| Minority Interest | ₹-6.39 Cr | ₹8.00 Cr | ₹12 Cr | ₹-1.93 Cr | ₹-0.88 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹1,159 Cr | ₹2,135 Cr | ₹619 Cr | ₹249 Cr | ₹168 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹1,159 Cr | ₹2,135 Cr | ₹619 Cr | ₹249 Cr | ₹168 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | ₹402 Cr | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | ₹400 Cr | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | ₹2.27 Cr | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-990 Cr | ₹-856 Cr | ₹-288 Cr | ₹122 Cr | ₹122 Cr |
| Deferred Tax Assets | ₹1,404 Cr | ₹1,336 Cr | ₹769 Cr | ₹430 Cr | ₹601 Cr |
| Deferred Tax Liability | ₹414 Cr | ₹480 Cr | ₹481 Cr | ₹552 Cr | ₹723 Cr |
| Other Long Term Liabilities | ₹308 Cr | ₹304 Cr | ₹363 Cr | ₹360 Cr | ₹360 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹283 Cr | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr |
| Total Non-Current Liabilities | ₹1,163 Cr | ₹1,809 Cr | ₹867 Cr | ₹903 Cr | ₹807 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹4,189 Cr | ₹4,454 Cr | ₹3,871 Cr | ₹2,703 Cr | ₹2,795 Cr |
| Sundry Creditors | ₹4,189 Cr | ₹4,454 Cr | ₹3,871 Cr | ₹2,703 Cr | ₹2,795 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹4,623 Cr | ₹3,161 Cr | ₹2,980 Cr | ₹3,107 Cr | ₹2,684 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹44 Cr | ₹233 Cr | ₹374 Cr | ₹562 Cr | ₹11 Cr |
| Interest Accrued But Not Due | ₹8.25 Cr | ₹2.68 Cr | ₹0.79 Cr | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹4,571 Cr | ₹2,925 Cr | ₹2,605 Cr | ₹2,544 Cr | ₹2,674 Cr |
| Short Term Borrowings | ₹5,310 Cr | ₹4,078 Cr | ₹4,230 Cr | ₹2,118 Cr | ₹4,804 Cr |
| Secured ST Loans repayable on Demands | ₹2,656 Cr | ₹1,822 Cr | ₹1,927 Cr | ₹289 Cr | ₹885 Cr |
| Working Capital Loans- Sec | ₹2,656 Cr | ₹1,822 Cr | ₹1,927 Cr | ₹289 Cr | ₹885 Cr |
| Buyers Credits - Unsec | ₹103 Cr | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-105 Cr | ₹434 Cr | ₹376 Cr | ₹1,540 Cr | ₹3,034 Cr |
| Short Term Provisions | ₹560 Cr | ₹506 Cr | ₹412 Cr | ₹229 Cr | ₹382 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹285 Cr | ₹249 Cr | ₹212 Cr | ₹58 Cr | ₹210 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹276 Cr | ₹257 Cr | ₹201 Cr | ₹171 Cr | ₹172 Cr |
| Total Current Liabilities | ₹14,682 Cr | ₹12,199 Cr | ₹11,494 Cr | ₹8,156 Cr | ₹10,665 Cr |
| Total Liabilities | ₹48,492 Cr | ₹43,859 Cr | ₹39,213 Cr | ₹33,633 Cr | ₹33,401 Cr |
| ASSETS | |||||
| Gross Block | ₹24,463 Cr | ₹23,448 Cr | ₹18,593 Cr | ₹15,943 Cr | ₹13,613 Cr |
| Less: Accumulated Depreciation | ₹9,659 Cr | ₹8,952 Cr | ₹7,570 Cr | ₹5,411 Cr | ₹4,240 Cr |
| Less: Impairment of Assets | ₹9.62 Cr | ₹2.74 Cr | - | - | - |
| Net Block | ₹14,794 Cr | ₹14,493 Cr | ₹11,024 Cr | ₹10,532 Cr | ₹9,374 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹3,266 Cr | ₹2,739 Cr | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr |
| Non Current Investments | ₹252 Cr | ₹322 Cr | ₹392 Cr | ₹618 Cr | ₹431 Cr |
| Long Term Investment | ₹252 Cr | ₹322 Cr | ₹392 Cr | ₹618 Cr | ₹431 Cr |
| Quoted | ₹103 Cr | ₹136 Cr | ₹208 Cr | ₹318 Cr | ₹154 Cr |
| Unquoted | ₹149 Cr | ₹185 Cr | ₹184 Cr | ₹301 Cr | ₹277 Cr |
| Long Term Loans & Advances | ₹973 Cr | ₹715 Cr | ₹794 Cr | ₹575 Cr | ₹658 Cr |
| Other Non Current Assets | ₹410 Cr | ₹256 Cr | ₹67 Cr | ₹38 Cr | ₹53 Cr |
| Total Non-Current Assets | ₹21,330 Cr | ₹19,653 Cr | ₹17,667 Cr | ₹15,510 Cr | ₹13,578 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹0.01 Cr | ₹51 Cr | ₹151 Cr | ₹379 Cr | ₹160 Cr |
| Quoted | ₹0.01 Cr | ₹51 Cr | ₹151 Cr | ₹379 Cr | ₹101 Cr |
| Unquoted | - | - | - | ₹0.70 Cr | ₹60 Cr |
| Inventories | ₹10,544 Cr | ₹9,808 Cr | ₹8,511 Cr | ₹7,554 Cr | ₹9,027 Cr |
| Raw Materials | ₹2,904 Cr | ₹2,920 Cr | ₹2,681 Cr | ₹2,374 Cr | ₹3,028 Cr |
| Work-in Progress | ₹1,638 Cr | ₹1,577 Cr | ₹1,407 Cr | ₹1,198 Cr | ₹1,302 Cr |
| Finished Goods | ₹4,230 Cr | ₹3,656 Cr | ₹3,141 Cr | ₹2,095 Cr | ₹2,449 Cr |
| Packing Materials | ₹462 Cr | ₹468 Cr | ₹378 Cr | ₹340 Cr | ₹355 Cr |
| Stores  and Spare | ₹341 Cr | ₹284 Cr | ₹322 Cr | ₹292 Cr | ₹238 Cr |
| Other Inventory | ₹968 Cr | ₹902 Cr | ₹582 Cr | ₹1,254 Cr | ₹1,655 Cr |
| Sundry Debtors | ₹5,746 Cr | ₹4,817 Cr | ₹4,466 Cr | ₹4,012 Cr | ₹3,503 Cr |
| Debtors more than Six months | ₹228 Cr | ₹249 Cr | ₹195 Cr | ₹205 Cr | ₹318 Cr |
| Debtors Others | ₹5,627 Cr | ₹4,691 Cr | ₹4,393 Cr | ₹3,899 Cr | ₹3,280 Cr |
| Cash and Bank | ₹8,235 Cr | ₹6,278 Cr | ₹6,084 Cr | ₹4,190 Cr | ₹5,474 Cr |
| Cash in hand | ₹0.21 Cr | ₹0.26 Cr | ₹7.95 Cr | ₹7.79 Cr | ₹0.28 Cr |
| Balances at Bank | ₹8,235 Cr | ₹6,278 Cr | ₹6,076 Cr | ₹4,182 Cr | ₹5,474 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹654 Cr | ₹519 Cr | ₹555 Cr | ₹394 Cr | ₹518 Cr |
| Interest accrued on Investments | ₹26 Cr | ₹20 Cr | ₹15 Cr | ₹16 Cr | ₹9.40 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | - | - | - | - | - |
| Other current_assets | ₹628 Cr | ₹500 Cr | ₹540 Cr | ₹378 Cr | ₹508 Cr |
| Short Term Loans and Advances | ₹1,983 Cr | ₹2,299 Cr | ₹1,692 Cr | ₹1,515 Cr | ₹1,058 Cr |
| Advances recoverable in cash or in kind | ₹449 Cr | ₹648 Cr | ₹490 Cr | ₹409 Cr | ₹333 Cr |
| Advance income tax and TDS | ₹2.78 Cr | ₹5.67 Cr | ₹76 Cr | ₹270 Cr | ₹79 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹1,531 Cr | ₹1,645 Cr | ₹1,126 Cr | ₹836 Cr | ₹646 Cr |
| Total Current Assets | ₹27,162 Cr | ₹23,772 Cr | ₹21,460 Cr | ₹18,044 Cr | ₹19,740 Cr |
| Net Current Assets (Including Current Investments) | ₹12,480 Cr | ₹11,573 Cr | ₹9,966 Cr | ₹9,888 Cr | ₹9,075 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹48,492 Cr | ₹43,859 Cr | ₹39,213 Cr | ₹33,633 Cr | ₹33,401 Cr |
| Contingent Liabilities | ₹368 Cr | ₹311 Cr | ₹159 Cr | ₹158 Cr | ₹141 Cr |
| Total Debt | ₹7,942 Cr | ₹6,315 Cr | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr |
| Book Value | 562.21 | 509.35 | 458.10 | 419.46 | 374.29 |
| Adjusted Book Value | 562.21 | 509.35 | 458.10 | 419.46 | 374.29 |
Compare Balance Sheet of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹66,243.1 Cr | 3.5% | 4.1% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.5% |
4.1% |
-17.6% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses